Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
JNJ-18038683 / J&J
NCT02466685: Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients	Completed	2	60	US	JNJ-18038683, Placebo	Herbert Meltzer, Janssen Research & Development, LLC	Bipolar Disorder
NCT03633357: Imaging 5HT7 Antagonist Effects in Bipolar Disorder	Recruiting	N/A	68	Europe	JNJ-18038683, Placebo	King's College London	Bipolar Disorder	06/22	06/22